Critical assessment of angiogenesis inhibitors in clinical trials.

被引：0
|
作者：
Eskens, F [1 ]
机构：
[1] Univ Rotterdam Hosp, Rotterdam, Netherlands
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P808
引用
收藏
页码：3816S / 3816S
页数：1
相关论文
共 50 条
  • [31] Angiogenesis (clinical trials)
    Laham, R
    CANADIAN JOURNAL OF CARDIOLOGY, 2001, 17 : 29A - 32A
  • [32] Angiogenesis clinical trials
    Ylä-Herttuala, S
    HUMAN GENE THERAPY: CURRENT OPPORTUNITIES AND FUTURE TRENDS, 2003, 43 : 19 - 23
  • [33] Establishing digital biomarkers for clinical trials.
    Thomas, Neil
    Mattek, Nora
    Riley, Thomas
    Witter, Phelps
    Reynolds, Christina
    Austin, Johanna
    Sharma, Nicole
    Marcoe, Jennifer
    Kaye, Jeffrey
    NEUROLOGY, 2018, 90
  • [34] Qualifying sites for oncology clinical trials.
    Kurbegov, Dax
    Kim, Edward S.
    Hurley, Patricia A.
    Waterhouse, David Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Experimental analytical trials. The clinical trial
    Conejero, Antonio Martin
    Garcia, Marcos Alonso
    ANGIOLOGIA, 2024, 76 (01): : 30 - 37
  • [36] Patient and clinical trials. Are they involved enough?
    Geissler, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S71 - S71
  • [37] Health-related quality of life assessment in EORTC cancer clinical trials.
    Zikos, Efstathios
    Coens, Corneel
    Ediebah, Divine Ewane
    Quinten, Chantal
    Greimel, Eva
    Flechtner, Henning
    Taphoorn, Martin J. B.
    Reijneveld, Jaap
    Koller, Michael
    Bottomley, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Diversity in multiple myeloma clinical trials.
    Duma, Narjust
    Velez, Miguel Gonzalez
    Vera-Aguilera, Jesus
    Parrondo, Richardo
    Mariotti, Veronica
    Paludo, Jonas
    Wang, Yucai
    Go, Ronald
    Adjei, Alex
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 68 - 68
  • [39] Ocular toxicity with MEK inhibitors in phase I trials: A single centre experience across six clinical trials.
    Michalarea, Vasiliki
    Luken, Maria Jose de Miguel
    Diamantis, Nikolaos
    Garg, Anurag
    Maubon, Laura
    Yap, Timothy Anthony
    Molife, L. Rhoda
    De Bono, Johann Sebastian
    Ursell, Paul
    Banerji, Udai
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Cancer pain assessment in clinical trials. A review of the literature (1999-2002)
    Caraceni, A
    Brunelli, C
    Martini, C
    Zecca, E
    De Conno, F
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) : 507 - 519
12345